Effigenta Cream 15gm




Effigenta Cream 15gm Indications

Effigenta Cream 15gm is primarily indicated in conditions like Acute diarrhoea, Bacterial infections, Biliary tract infections, Endocarditis, Food allergy, Muscle relaxation intermediate duration) during intensive care, Muscle relaxation (intermediate duration) for surgery or intubation, Muscle relaxation (long duration) during intensive care, Pneumonia in hospital patients, Septicaemia, Ulcerative colitis and crohn’s disease, Urinary tract infection, and can also be given in adjunctive therapy as an alternative drug of choice in Solid tumor.


Effigenta Cream 15gm is contraindicated in conditions like Renal diseases, Hypersensitivity.

Side Effects

The severe or irreversible adverse effects of Effigenta Cream 15gm, which give rise to further complications include Encephalopathy, Convulsions, Hallucinations, Nephrotoxicity, Hallucinations, Neuromuscular blockage, Peripheral neuritis, Anaemia. Effigenta Cream 15gm produces potentially lifethreatening effects which include Neuromuscular blockage, Nephrotoxicity, Ototoxicity. which are responsible for the discontinuation of Effigenta Cream 15gm therapy. The symptomatic adverse reactions produced by Effigenta Cream 15gm are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Vertigo, Fever, Ototoxicity, Skin rashes, Exfoliative dermatitis, Eosinophilia, Purpura, Angioedema, Pyuria, Proteinuria, Azotemia, Cylindruria, Local allergies, Skin rashes, Cross sensitivity, dizziness.


Effigenta Cream 15gm should be used with caution in patients with history of kidney diseases, vertigo, hearing loss, myasthenia gravis, parkinsonisms. It should be used with caution in patients who are sensitive to aminoglycosides. Keep patients well hydrated to prevent chemical irritation or nephrotoxic reactions. Take appropriate measures in case of secondary infections.


There are no reviews yet.

Be the first to review “Effigenta Cream 15gm”

Your email address will not be published. Required fields are marked *